These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 27058526)

  • 1. Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models.
    Kimura N
    Int J Mol Sci; 2016 Apr; 17(4):503. PubMed ID: 27058526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus accelerates Aβ pathology in brain accompanied by enhanced GAβ generation in nonhuman primates.
    Okabayashi S; Shimozawa N; Yasutomi Y; Yanagisawa K; Kimura N
    PLoS One; 2015; 10(2):e0117362. PubMed ID: 25675436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease.
    Ramos-Rodriguez JJ; Jimenez-Palomares M; Murillo-Carretero MI; Infante-Garcia C; Berrocoso E; Hernandez-Pacho F; Lechuga-Sancho AM; Cozar-Castellano I; Garcia-Alloza M
    Psychoneuroendocrinology; 2015 Dec; 62():69-79. PubMed ID: 26254770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type II Diabetes Mellitus Accelerates Age-Dependent Aβ Pathology in Cynomolgus Monkey Brain.
    Kimura N
    Adv Exp Med Biol; 2019; 1128():133-145. PubMed ID: 31062328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
    Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New animal models of Alzheimer's disease that display insulin desensitization in the brain.
    Gao C; Liu Y; Li L; Hölscher C
    Rev Neurosci; 2013; 24(6):607-15. PubMed ID: 24259244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential.
    Sato N; Takeda S; Uchio-Yamada K; Ueda H; Fujisawa T; Rakugi H; Morishita R
    Curr Aging Sci; 2011 Jul; 4(2):118-27. PubMed ID: 21235496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.
    Takeda S; Sato N; Rakugi H; Morishita R
    Mol Biosyst; 2011 Jun; 7(6):1822-7. PubMed ID: 21431241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
    Stanley M; Macauley SL; Holtzman DM
    J Exp Med; 2016 Jul; 213(8):1375-85. PubMed ID: 27432942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and Molecular Mechanisms of Dementia: Decoding the Causal link of Diabetes Mellitus in Alzheimer's Disease.
    Rasool M; Malik A; Waquar S; Zaheer A; Asif M; Iqbal Z; Gauthaman K; Kamal MA; Pushparaj PN
    CNS Neurol Disord Drug Targets; 2021; 20(7):602-612. PubMed ID: 33583389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-β and tau pathology of Alzheimer's disease induced by diabetes in a rabbit animal model.
    Bitel CL; Kasinathan C; Kaswala RH; Klein WL; Frederikse PH
    J Alzheimers Dis; 2012; 32(2):291-305. PubMed ID: 22785400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of insulin resistance in Alzheimer's disease.
    Cai Z; Xiao M; Chang L; Yan LJ
    Metab Brain Dis; 2015 Aug; 30(4):839-51. PubMed ID: 25399337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse models of Alzheimer's disease: the long and filamentous road.
    Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
    Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
    Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
    J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function -- role of glucose metabolism and insulin signalling.
    Rhein V; Eckert A
    Arch Physiol Biochem; 2007 Jun; 113(3):131-41. PubMed ID: 17922309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axonopathy Likely Initiates Neuropathological Processes Via a Mechanism of Axonal Leakage in Alzheimer's Mouse Models.
    Gao G; He J; Luo Y; Sun Y; Zhou Y; Zhang J; Xing Y; Dai J
    Curr Mol Med; 2019; 19(3):183-195. PubMed ID: 30961496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.